CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-15 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 40,500 | ||
| 2024-09-14 | Markowitz Wayne GM & SVP, Surgical | Shares withheld for taxes | −648 | $68.52 | $44K | 10,033.05 |
| 2024-09-13 | Dahl Andrew M. SVP, Corporate Controller | Grant or award | +2,920 | 4,690.78 | ||
| 2024-09-11 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-09-11 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $66.77 | $334K | 46,935.72 |
| 2024-09-11 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 45,500 | ||
| 2024-09-03 | Szyman Catherine M. CVP, Critical Care | Grant or award | +10,910 | 86,817.44 | ||
| 2024-09-03 | Szyman Catherine M. CVP, Critical Care | Shares withheld for taxes | −5,530 | $69.96 | $387K | 81,287.44 |
| 2024-08-20 | Chopra Daveen CVP, TMTT | Sale | −1,250 | $69.95 | $87K | 29,333 |
| 2024-08-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-08-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $66.08 | $330K | 46,935.72 |
| 2024-08-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 50,500 | ||
| 2024-07-11 | Lippis Daniel J. CVP, JAPAC | Option exercise 10b5-1 | +500 | $45.28 | $23K | 23,689.07 |
| 2024-07-11 | Lippis Daniel J. CVP, JAPAC | Sale 10b5-1 | −500 | $94.18 | $47K | 23,189.07 |
| 2024-07-11 | Lippis Daniel J. CVP, JAPAC | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −500 | 4,530 | ||
| 2024-07-10 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +5,000 | $45.28 | $226K | 51,935.72 |
| 2024-07-10 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −5,000 | $93.29 | $466K | 46,935.72 |
| 2024-07-10 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 55,500 | ||
| 2024-07-10 | Feinberg David T Director | Grant or award | +2,308 | 2,308 | ||
| 2024-07-07 | Szyman Catherine M. CVP, Critical Care | Shares withheld for taxes | −258 | $92.32 | $24K | 75,907.44 |
Page 20 of 27 · 525 trades